Regencell Bioscience
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-03-31 |
|---|---|---|
Gross Profit | -363 | -40 |
EBITDA | -6,020 | -5,299 |
EBIT | -6,383 | -5,340 |
Net Income | -6,383 | -5,317 |
Free Cash Flow | -5,103 | -2,591 |
Cash | 14,192 | 2,357 |
Basic Shares | 494,698 | 494,488 |
Annual Financials
| Values in thousands | 2024-06-30 | 2023-06-30 |
|---|---|---|
Revenue | $0 | $0 |
Gross Profit | -745 | -769 |
EBITDA | -3,617 | -5,292 |
EBIT | -4,363 | -6,062 |
Net Income | -4,301 | -5,871 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -4,007 | -4,990 |
Cash | 2,961 | 1,564 |
Basic Shares | 494,488 | 494,488 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-03-31 | $0 |
2024-09-30 | $0 |
2022-09-30 | -$0.30 |